Please assess the completion status of the following clinical trial:

Trial Title: Effects of Nebivolol on Subclinical Left Ventricular dySfunction: A Comparative Study Against Metoprolol

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* aged 18 years or older, men and women, hospitalized and outpatients~* with a history of primary arterial hypertension~* with a daytime ambulatory blood pressure \>140 and/or \>90 mm Hg~* with left ventricular hypertrophy: LVMI \> 125 g/m2 for men, and \> 110 g/m2 for women, by Devereux formula, as recommended by the ESH-ESC guidelines (14)~* in sinus rhythm~* consented, by signing the Informed Consent~Exclusion Criteria:~* Severe arterial hypertension (systolic blood pressure \> 180 mm Hg and/or diastolic blood pressure \> 110 mm Hg)~* Any history of coronary heart disease (stable angina, acute coronary syndromes, myocardial infarction)~* Any history of cerebrovascular disease~* Renal impairment (creatinine \> 1.5 mg% for men, \> 1.4 mg% for women)~* Left ventricular global systolic dysfunction (EF \< 45%)~* More than mild valvar (mitral or aortic) regurgitation~* Hypertrophic cardiomyopathy~* Pericarditis~* Cor pulmonale~* Pregnancy or lactating women~* Any significant co-morbidities~* Contraindication to beta-blocker therapy~* Concomitant treatment with other beta-blockers~* Participation to another investigational study in the last 3 months

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Nebivolol (Type: EXPERIMENTAL): None
- Metoprolol (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).